AFP and liver cancer: According to the Barcelona Clinic Liver Cancer (BCLC) classification, 3 patients were stage A, 65 were stage B, and 79 were stage C. Regarding tumor markers, the median AFP level was 50.1 ng/mL (range, 1.8–2,037,310), and 96 patients (65.3%) had AFP ≥ 10 ng/mL.